Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/21/2013WO2013112806A3 Transdermal hormone delivery
11/21/2013WO2013084210A9 Amorphous form of sitagliptin salts
11/21/2013WO2013084147A3 Antibodies for epidermal growth factor receptor 3 (her3)
11/21/2013WO2013032558A4 Products for anti-inflammation support
11/21/2013WO2012125438A8 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
11/21/2013WO2012104206A9 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof
11/21/2013WO2012065121A3 Metabolized conditioned growth medium and methods of use
11/21/2013US20130312126 Methods and Compositions for RNAi Mediated Inhibition of Gene Expression in Mammals
11/21/2013US20130310732 Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
11/21/2013US20130310565 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/21/2013US20130310562 Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors
11/21/2013US20130310545 Inhibitors of Branched-Chain-Aminotransferase-1 (BCAT1) for the Treatment of Brain Tumors
11/21/2013US20130310463 Aromatase Activator
11/21/2013US20130310462 Supramolecular complexes of polyanionic polymers and spermidine in tissue maintenance and repair
11/21/2013US20130310461 Stabilized compositions of volatile alkylating agents and methods of using thereof
11/21/2013US20130310460 Modified release formulations of memantine oral dosage forms
11/21/2013US20130310456 Acamprosate formulations, methods of using the same, and combinations comprising the same
11/21/2013US20130310455 Acamprosate formulations, methods of using the same, and combinations comprising the same
11/21/2013US20130310454 Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease
11/21/2013US20130310453 Green garlic and methods of production
11/21/2013US20130310451 Tricyclic lactones for treatment of cancer
11/21/2013US20130310449 Functional foods and beverages with synergistic properties to promote homeostasis
11/21/2013US20130310448 Methods and compositions for inhibition of atr and fancd2 activation
11/21/2013US20130310447 Pharmaceutical composition of taxoids
11/21/2013US20130310445 Oligonucleotide chelate complex methods
11/21/2013US20130310444 Combination Therapy for Cancer
11/21/2013US20130310442 SDF-1 Binding Nucleic Acids and the use Thereof in Cancer Treatment
11/21/2013US20130310441 ANTISENSE OLIGONUCLEOTIDES AGAINST AchE IN THE TREATMENT OF GASTROINTESTINAL INFLAMMATION DISORDERS
11/21/2013US20130310440 Method for treating non-small cell lung cancer
11/21/2013US20130310439 Method of reducing proteins misfolding and/or aggregation
11/21/2013US20130310437 Combination for the treatment of osteoarthritis
11/21/2013US20130310436 Methods for predicting response to beta-blocker therapy in non-ischemic heart failure patients
11/21/2013US20130310435 Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
11/21/2013US20130310434 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4'9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
11/21/2013US20130310433 Thiophene-carboxamides useful as inhibitors of protein kinases
11/21/2013US20130310432 Novel thiazolidin-4-one-derivatives
11/21/2013US20130310431 Uses for substituted 2-amino-thiazolones in treating alzheimer's disease
11/21/2013US20130310430 Compositions and methods of using (r)-pramipexole
11/21/2013US20130310429 ITE for Cancer Intervention and Eradication
11/21/2013US20130310426 Sustained release aminopyridine composition
11/21/2013US20130310424 Aerosol pirfenidone and pyridone analog compounds and uses thereof
11/21/2013US20130310422 Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine
11/21/2013US20130310421 Treatment of amyloid beta amyloidosis
11/21/2013US20130310420 Stable formulations of pitavastatin
11/21/2013US20130310419 Pyrrole derivatives used as modulators of alpha7 nachr
11/21/2013US20130310416 Methods and Compositions for Preventing or Treating Age-Related Diseases
11/21/2013US20130310415 Morphinan compounds
11/21/2013US20130310414 Therapeutic or prophylactic agent for cachexia
11/21/2013US20130310413 Abuse-deterrent drug formulations
11/21/2013US20130310412 Combinations of an Opioid/TLR4 Antagonist and a Direct-Acting Alpha-2 Adrenergic Agonist for Use in the Treatment of Pain
11/21/2013US20130310407 Combinations comprising macitentan for the treatment of glioblastoma multiforme
11/21/2013US20130310405 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the pi3k/akt pathway
11/21/2013US20130310402 Use of inhibitors of bruton's tyrosine kinase (btk)
11/21/2013US20130310398 Combination therapy for the treatment of diabetes and related conditions
11/21/2013US20130310397 Ternary mixture formulations
11/21/2013US20130310396 Thiazolidine derivatives and their therapeutic use
11/21/2013US20130310395 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013US20130310392 Pharmaceutical formulation for topical administration comprising b220
11/21/2013US20130310388 Modulators of TNF-Alpha Signaling
11/21/2013US20130310387 Monocyclic Heteroaryl Cycloalkyldiamine Derivatives
11/21/2013US20130310386 Methods of treating eye diseases associated with inflammation and vascular proliferation
11/21/2013US20130310385 Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
11/21/2013US20130310381 Substituted sodium-1h-pyrazole-5-olate
11/21/2013US20130310380 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
11/21/2013US20130310372 Pharmaceutical transdermal compositions and method for treating inflammation in cattle
11/21/2013US20130310371 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
11/21/2013US20130310370 Drug therapy for preventing or treating glaucoma
11/21/2013US20130310369 Salts of lorcaserin with optically active acids
11/21/2013US20130310367 Method of enhancing performance in broiler chickens
11/21/2013US20130310366 5-ht3 receptor modulators, methods of making, and use thereof
11/21/2013US20130310364 Compositions and methods for inhibition of the jak pathway
11/21/2013US20130310362 Fused pyrimidines
11/21/2013US20130310361 Compounds and compositions as kinase inhibitors
11/21/2013US20130310357 Azolyl Urea Compounds and Methods of Use Thereof
11/21/2013US20130310356 Method for treating brain cancer
11/21/2013US20130310355 Low toxicity topical active agent delivery system
11/21/2013US20130310354 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
11/21/2013US20130310353 Novel quinuclidine derivatives and medicinal compositions containing the same
11/21/2013US20130310352 Dexamethasone combination therapy
11/21/2013US20130310351 Treating Long QT Syndrome
11/21/2013US20130310350 Method for the treatment of central nervous system cancers and compositions related thereto
11/21/2013US20130310348 Quinoline derivatives and uses thereof
11/21/2013US20130310346 Methods and compositions for treating bacterial infections with iron chelators
11/21/2013US20130310345 Use of TRPA1 Antagonists to Prevent or Treat Infections Caused by Biological-Warfare Agents
11/21/2013US20130310341 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
11/21/2013US20130310340 Method of treating muscular degradation
11/21/2013US20130310339 Sexual function improving agent
11/21/2013US20130310338 Glucans
11/21/2013US20130310336 Methods and compositions for treating flaviviruses and pestiviruses
11/21/2013US20130310335 Prolonged release bioadhesive therapeutic systems
11/21/2013US20130310330 Method for treating obesity
11/21/2013US20130310329 Combined therapy for cystic fibrosis
11/21/2013US20130310325 Administration of serine protease inhibitors to the stomach
11/21/2013US20130310320 Boronic ester and acid compounds, synthesis and uses
11/21/2013US20130310312 Combination of insulin with triazine derivatives and its use for treating diabetes
11/21/2013US20130310253 Cholesterol lowering agent, neutral fat lowering agent, blood glucose level lowering agent, cholesterol adsorbent, adsorbent, neutral fat adsorbent, healthy food, health supplement, food with nutrient function claims, food for specified health use, quasi-drug, and pharmaceutical drug
11/21/2013US20130309331 Compositions and Methods for Treating the Symptoms Associated for Alcohol Based Hangovers
11/21/2013US20130309330 Compositions comprising a prostaglandin for treating neuropsychiatric conditions
11/21/2013US20130309329 Methods and compositions for treating, reducing or preventing deterioration of the visual system of animals
11/21/2013US20130309326 Morphine and morphine precursors
1 ... 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 ... 7860